Boven, E.

patient hypertension sunitinib treatment grade 3 hypertension polymorphism survival analysis blood sunitinib treatment cancer grade pressure study factor cycle therapy haplotype change center baseline vegfa netherland treatment cycle diastolic blood pressure association acg haplotype outcome blood pressure university disease systolic blood pressure number vegfr multivariate tumor sunitinib therapy growth level oncology department sunitinib-induced systolic regression analysis oxide nitric growth factor metastatic growth factor receptor diastolic value presence month synthase inhibitor characteristic clear-cell type disease sites oncol cell cancer sunitinib-induced hypertension regression october antihypertensive blood vessel tone group increase carcinoma 0.4 vegfr -2 progression-free survival volume addition table sunitinib-treated patients hypertension grades article myelosuppression cell carcinoma variable